Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis
The latest in news from I-MAK experts.
For press inquiries, please contact simon@i-mak.org.
NYU Law Magazine profiles Priti Radhakrishnan
Scripnews.com covers Tahir Amin on expert patent review
India Rejects Gilead’s Tenofovir Patent Applications
The Treatment Timebomb
Brazilian Patent Office Issues Final Refusal for Tenofovir – But Gilead Files Divisional Application
UK All-Party Parliamentary Group on Aids to Urge Companies to Pool HIV Patents
Parliamentary Standing Committee Releases Report on Improving the Patent and Trade Mark Systems in India
Divide and Rule: Companies File ‘Divisional’ Applications to Avoid Oppositions Against HIV Drug Patents
Divisional or Continuation Application? Abbott Re-Files the Same Application
Update India: Abbott Files a Divisional Application for its Heat Stable Ritonavir/Lopinavir Formulation